当前位置:药药网 / 数据中心 / PubMed 中的摘要说明,变体和药物之间的可能关系
氯吡格雷
文献标题
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban
杂志
Pharmacogenomics and Personalized Medicine
句子
In some trials the variability in response to clopidogrel was observed, which is connected with numerous factors, CYP2C19-dependent active metabolite production among them. , Though the presence of low function alleles CYP2C19*2 ( rs4244285, c.681G>A ) and CYP2C19*3 ( rs4986893, c.636G>A ) leads to an insufficient platelet activity inhibition and significantly increases the risk of thrombotic complications compared to non-carriers. , CYP2C19*17 carriership is connected to an increased risk of bleeding complications on clopidogrel.